EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

High prevalence of severe pain is associated with low opioid availability in patients with advanced cancer: Combined database study and nationwide questionnaire survey in Japan

Maiko Hasegawa-Moriyama, Yasuhide Morioka iD, Shinzo Hiroi, Noriyuki Naya, Yura Suzuki, Yuichi Koretaka, Erina Hara, Hiroaki Abe, Kanji Uchida, Masahiko Sumitani iD

Neuropsychopharmacology Reports · 2024

DOI: 10.1002/npr2.12448 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuropsychopharmacology Reports, 2024. Verfasst von Maiko Hasegawa-Moriyama und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pain and Palliative Medical Sciences, Faculty of Medicine, The University of Tokyo, Tokyo, Japan. Hauptthemen laut MEDLINE: Analgesics, Opioid, Cancer Pain, Neoplasms, Databases, Factual. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shionogi, Nippon Zoki Pharmaceutical, Heartfelt Inc.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Opioid availability for the palliative care of patients with advanced cancer is increasing globally. However, opioid availability remains extremely low in Japan. We investigated whether pain is appropriately controlled by low‐dose opioid prescriptions in patients with advanced cancer in Japan.

Methods

A web‐based nationwide survey for caregivers from 2000 community comprehensive support care centers was performed in Japan to assess details about pain in the 30 days before patients died of end‐stage cancer. Separately, the data for opioid prescription doses and medical services in the 90 days before the death of patients with cancer were extracted from a health insurance claim database.

Results

Responses from 1034 responders were retrieved and 665 patients were included. In total, 254 patients (38.2%) complained of severe‐to‐intolerable cancer‐related pain. The median cumulative prescription dose of opioids in the 90 days before patient death was 311.0 mg by oral morphine equivalent doses. Multiple regression analyses across prefectures revealed that the proportion of patients with severe‐to‐intolerable cancer‐related pain was negatively associated with the cumulative opioid consumption expressed as morphine‐equivalent doses within 90 days before death.

Conclusions

The very low availability of opioids for patients with end‐stage cancer could result in high rate of severe‐to‐intolerable cancer‐related pain patients. There were several limitations in this study, and the interpretations of the findings should be carefully. However, the increase in the absolute dose of opioids could improve the palliative care framework to the pain control levels of the global standard.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Analgesics, OpioidCancer PainNeoplasmsDatabases, FactualHumansJapanMaleFemaleAgedMiddle AgedPrevalenceSurveys and QuestionnairesPalliative CareAdultAged, 80 and over

Stichwörter der Autor:innen

cancer‐related painend‐stage cancer patientsopioid prescriptionpalliative care

Substanzen

Analgesics, Opioid

Autor:innen und Institutionen

  • Department of Pain and Palliative Medical Sciences, Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
  • Medical Affairs Department, Shionogi & Co., Ltd., Osaka, Japan.
  • Data Science Department, Shionogi & Co., Ltd., Osaka, Japan.
  • Department of Anesthesiology and Pain Relief, The University of Tokyo Hospital, Tokyo, Japan.
  • Department of Pain and Palliative Medicines, The University of Tokyo Hospital, Tokyo, Japan.

ORCID-Profile: Yasuhide Morioka, Masahiko Sumitani

Förderung

  • Shionogi
  • Nippon Zoki Pharmaceutical
  • Heartfelt Inc
  • Aiwa Hospital

Zitieren

APA

Hasegawa-Moriyama, M., Morioka, Y., Hiroi, S., Naya, N., Suzuki, Y., Koretaka, Y., Hara, E., Abe, H., Uchida, K., & Sumitani, M. (2024). High prevalence of severe pain is associated with low opioid availability in patients with advanced cancer: Combined database study and nationwide questionnaire survey in Japan. Neuropsychopharmacology Reports. https://doi.org/10.1002/npr2.12448

Vancouver

Hasegawa-Moriyama M, Morioka Y, Hiroi S, Naya N, Suzuki Y, Koretaka Y, et al. High prevalence of severe pain is associated with low opioid availability in patients with advanced cancer: Combined database study and nationwide questionnaire survey in Japan. Neuropsychopharmacology Reports. 2024. doi:10.1002/npr2.12448

BibTeX
@article{HasegawaMoriyama2024,
  author = {Hasegawa-Moriyama, Maiko and Morioka, Yasuhide and Hiroi, Shinzo and Naya, Noriyuki and Suzuki, Yura and Koretaka, Yuichi and Hara, Erina and Abe, Hiroaki and Uchida, Kanji and Sumitani, Masahiko},
  title = {High prevalence of severe pain is associated with low opioid availability in patients with advanced cancer: Combined database study and nationwide questionnaire survey in Japan},
  journal = {Neuropsychopharmacology Reports},
  year = {2024},
  doi = {10.1002/npr2.12448}
}
Kostenlos starten →